Jan 12, 2024, 01:00 AM by User Not Found

Bio-IT World | Christian Henry, President and CEO of Pacific Biosciences, was unabashedly cheerful at the JP Morgan Healthcare Conference on Wednesday afternoon when he gave the updates for PacBio. “2023 absolutely exceeded our expectations,” he said, basking in two platform launches, strong consumable growth, and three new platforms in development.

Jan 10, 2024, 08:46 AM by

PubHive elevates local literature workflow: Unprecedented Automation for Online and Paper Journals Enhances Global Pharmacovigilance Efficiency.

Jan 10, 2024, 08:46 AM by

EMTELLIGENT'S EMTELLIPRO MEDICAL AI PLATFORM NAMED ONE OF THE MOST INTERESTING INNOVATIONS OF 2023 BY PM360

Jan 10, 2024, 01:00 AM by User Not Found

Bio-IT World | CEO Jacob Thaysen presented Illumina’s updates yesterday at the JP Morgan Healthcare Conference. 2023 has been an eventful year for the sequencing pioneer with December’s announcement that Illumina would divest GRAIL; Francis deSouza, Illumina’s former CEO, stepping down in June; and $175M in cost cuts over the course of 2023 which included headcount reductions and major real estate changes. Thaysen presented Illumina at a turning point.

Jan 9, 2024, 06:26 AM by

I wanted to reach out with the latest news from Verdot, who have recently forged a strategic partnership with Bio-Link, a prominent Chinese bioprocessing company. The collaboration aims to advance biopharmaceutical manufacturing in China, with Bio-Link becoming the major distributor for Verdot’s innovative chromatography columns in the Chinese market The full release and images are below. Thank you Charlotte

Jan 9, 2024, 01:00 AM by User Not Found

Bio-IT World | Chris Gibson, CEO of Recursion, launched a live demo of Recursion’s new large language model orchestration work engine, LOWE, yesterday at the JP Morgan Healthcare Conference. The tool is the next step toward Recursion’s goal of autonomous drug discovery.

Jan 8, 2024, 17:04 PM by User Not Found

Bio-IT World | Drug design is at a tipping point, Kimberly Powell, vice president of Healthcare for NVIDIA, argued in her Monday morning presentation at the JP Morgan Healthcare Conference. “Two necessary conditions have arrived for drugs: digitizing biology and being able to represent it in a computer. We have the perfect conditions to see a massive expansion of this computer-aided drug discovery industry,” she said. And generative AI is the class of tools that will facilitate it.

Jan 8, 2024, 08:12 AM by

Jan 8, 2024, 08:12 AM by

Jan 8, 2024, 08:12 AM by

Jan 5, 2024, 09:55 AM by

X-Chem executives transition into new roles: Karen Lackey will serve as Chief Executive Officer and Matt Clark becomes X-Chem President and Chief Scientific Officer.

Jan 5, 2024, 09:55 AM by

Leading organizations partner to bring clinical best practices and innovative tools to healthcare professionals nationwide.

Jan 5, 2024, 01:00 AM by User Not Found

Bio-IT World | Driven by advancements in technology and data accessibility, computational methods and artificial intelligence (AI) have seen remarkable growth this past decade. This surge has ushered in a new era of problem-solving across a plethora of industries and domains.

Jan 4, 2024, 10:01 AM by User Not Found

Bio-IT World | Spatial biology, large language models, and new informatics tools. Bio-IT is exploring how AI fits into workstreams, still wrangling with data management challenges, and shaping discovery for the new era. Here are the top stories from Bio-IT World as well as thought leaders in the industry.

Jan 4, 2024, 09:01 AM by

Demonstrates Commitment to Delivering Superior Products and Services to Customers

Jan 3, 2024, 08:52 AM by

PubHive tackles pharmacovigilance inefficiencies! Centralized SmPC management and AI workflows boost speed, compliance, and patient safety.

Jan 3, 2024, 01:00 AM by User Not Found

Bio-IT World | To kick off the New Year, we spoke with leaders and experts in the Bio-IT community about their predictions for 2024.

Jan 2, 2024, 09:12 AM by

Jan 2, 2024, 09:12 AM by

Jan 2, 2024, 09:12 AM by